Review
Year 2020,
Volume: 5 Issue: 1, 38 - 48, 30.04.2020
Abstract
Meme kanseri dünyada ve ülkemizde kadınlar arasında en çok görülen kanser türüdür. Teknolojinin ilerlemesiyle birlikte meme kanserinin tedavisinde; cerrahi, kemoterapi, radyoterapi, hormonoterapi, hedef tedavi ve immunoterapi gibi seçenekler yer almaktadır. Bu tedavi seçeneklerinin bir veya birden fazlası hastanın klinik durumuna göre tercih edilmektedir. Kullanılan tedavi yöntemleri, kanserin evresi ve hastada bulunan bazı etkenlere bağlı olarak bulantı-kusma, konstipasyon, diyare, alopesi, mukozit, nötropeni, yorgunluk gibi yan etkiler görülmekte ve bireyin yaşam kalitesini olumsuz biçimde etkilemektedir. Tamamlayıcı tedaviler, tıbbi tedavilere destek amacıyla kullanılır. Hastalar tamamlayıcı tedavileri; semptomları ve ilaçlara bağlı yan etkileri azaltmak, yaşam kalitelerini iyileştirmek, fiziksel ve psikolojik olarak destek almak amacıyla kullanmaktadır. Tamamlayıcı tedavi kullanımı yaş, eğitim düzeyi, gelir durumu, kanser evresi, fiziksel aktivite, beslenme tarzı, kültürel farklılıklar, coğrafi bölge, etnik kökene bağlı olarak değişiklik göstermektedir. Bu derleme dünyada ve ülkemizde meme kanseri olan hastaların kullandıkları tamamlayıcı ve alternatif tedavi yöntemleri konusunda farkındalık oluşturmak için düzenlenmiştir.
Keywords
Supporting Institution
Destekleyen Kurum yoktur.
References
- 1. https://www.uicc.org. new-global-cancer-data-globocan. 2018. 2. Cordosa F, Kyriakides S. (2019). Early Breast Cancer: ESMO Clinical Practice Guideline For Diagnosis, Treatment And Follow-Up. Annals Of Oncology 30: 1194–1220. 3. Breast Cancer Statistics 2019 in CA: A Cancer Journal for Clinicians. 4. Ozmen V. (2008). Breast Cancer in the world and Turkey. The Journal of Breast Health 4:1-4. 5. Aydıner A, Topuz E. (2006). Meme Kanseri Tanı , Tedavi ,Takip. İstanbul Konsensusu. Nobel Tıp Kitapevi. 6. Kurt S, Unsar S. (2011). Assessment of symptom control in patients with cancer in Northwestern Turkey. European Journal of Oncology Nursing 15 (2), 137-144. 7. Liao G, Apaya M, Shyur L. (2013). Herbal Medicine and Acupuncture for Breast Cancer Palliative Care and Adjuvant Therapy. Hindawi Publishing, 437, 17-23. 8. Algier LA, Hanoglu Z, Ozden G, Kara F. (2005). The use of complementary and alternative (non-conventional) medicine in cancer patients in Turkey. Eur J Oncol Nurs 9:138-46. 9. Ozlem ER, Mistik S, Ozkan M, Ozturk A, Altinbas M. (2008). Factors related to complementary/ alternative medicine use among cancer patients in central Anatolia. Tumori, 94, 833-7. 10. National Center for Complementary and Integrative Health [Internet]. Maryland: National Institutes of Health: 2017 [updated 2019 oct 14]. Available from: https://nccih.nih.gov/health/integrative-health 11. Yildirim YK, Fadiloğlu C, Uyar M. (2006). Complementary therapies in palliative cancer care. [Article in Turkish] Agri 18(1):26–32. 12. Libing Zhu, Lingru Li, Yingshuai Li, Ji Wang, Qi Wang. (2016). Chinese Herbal Medicine as an Adjunctive Therapy for Breast Cancer: A Systematic Review and Meta-Analysis. Evidence-based complementary and alternative medicine. 13. Tian H, Qin W Wenjing Wu, Pi Guo, Yong Lu,Pengxi Liu, Qiang Liu, Fengxi S. (2015). Effects of Traditional Chinese Medicine on Chemotherapy Induced Myelosuppression and Febrile Neutropenia in Breast Cancer Patients. Evidence-Based Complementary and Alternative Medicine. 14. Wu H‐J, Tai C‐J, Tai C‐J, Chien L‐Y. (2019). Symptom severity, symptom interference and use of complementary and alternative medicine among survivors of colorectal and breast cancer after curative treatment in Taiwan. European Journal of Cancer Care. 15. Kang E. Yang E.J. Kim SM, Chung IY, Han SA, Ku DH, Nam SJ, Yang JH, Kim SW. (2012). Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study. Support Care Cancer 20:461–473 16. Hwang HJ, Kim WY, Ahmed M, Choi S, Kim J, Han DW. (2015). The Use of Complementary and Alternative Medicine by Korean Breast Cancer Women: Is It Associated with Severity of Symptoms? Evidence-Based Complementary and Alternative Medicine. 17. Kang DH, McArdle T, Suh Y.(2014). Changes in Complementary and Alternative Medicine Use Across Cancer Treatment and Relationship to Stress, Mood, and Quality of Life. The Journal Of Alternatıve And Complementary Medıcıne. pp. 1–7 18. Jeong YJ, Kwak MA, Seo JC,Park SH, Bong JG, Shin IH , Park SH. (2018). Acupuncture for the Treatment of Taxane-Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot Trial. Evidence-Based Complementary and Alternative Medicine Volume 19. Saibul N, Shariff MZ, Rahmat A, Sulaiman S, Yaw YH. (2012). Use of Complementary and Alternative Medicine among Breast Cancer Survivors. Asian Pacific J Cancer Prev 13: 4081-4086 20. Chui PL, Abdullah KL, Wong LP, Taip NA. (2017). Complementary and Alternative Medicine Use and Symptom Burden in Women Undergoing Chemotherapy for Breast Cancer in Malaysia. Cancer Nursing. 21. McLay J.S. Stewart D, George J, Rore C, Heys SD. (2012). Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions? Eur J Clin Pharmacol 68:811–819 22. Alsharif FH, Mazanec SR. (2019). The use of complementary and alternative medicine among women with breast cancer in Saudi Arabia. Applied Nursing Research 48:75–80 23. Bright-Gbebry M, Makambi H, Rohan JP, Llanos AA, Rosenberg L, Palmer JR, Adams-Campbell LL. (2011). Use of multivitamins, folic acid and herbal supplements among breast cancer survivors: the black women’s health study. BMC Complementary and Alternative Medicine, 11:30 24. Rush CL, Lobo T, Serrano A, Blasini M, Campos C, Graves K.D. (2016). Complementary and Alternative Medicine Use and Latina Breast Cancer Survivors’ Symptoms and Functioning. Healthcare, 4, 80 25. Templeton AJ, Thürlimann B, Baumann M, Mark M, Stoll S, Schwizer M, Dietrich D, Ruhstaller T. (2013). Cross-sectional study of self-reported physical activity, eating habits and use of complementary medicine in breast cancer survivors. BMC Cancer, 13:153 26. Sarvarya A, Sarvarya A. (2019). Use of complementary and alternative medicine among breast cancer patients in Hungary: A descriptive study. Complementary Therapies in Clinical Practice 35:195–200 27. Yavuz M, Özcan İlçe A, Kaymakçı Ş, Bildik G, Dıramalı A. (2007). Meme Kanserli Hastaların Tamamlayıcı ve Alternatif Tedavi Yöntemlerini Kullanma Durumlarının İncelenmesi. Turkiye Klinikleri 680 J Med Sci, 27 28. Can G, Demir M, Aydıner A. (2012). Complementary and Alternative Therapies Used by Turkish Breast Cancer Patients Undergoing Chemotherapy. Breast Care. 7:471–475 29. Kurt H. Keşkek Ş, Çil T, Canataroğlu A. (2013). Meme kanserli hastalarda tamamlayıcı/ alternatif tedavi kullanımı. Türk Onkoloji Dergisi. 28(1):10-15 30. Aslan M. (2014). Meme Kanserli Kadın Hastalarda Kemoterapiye Bağlı Gelişen Bulantı, Kusma ve Öğürme Üzerine Zencefil Kullanımının Etkisi. Hacettepe Üniversitesi Sağlık Bilimleri Enstitüsü. Ankara. 31. Gül A, Üstündağ H, Andsoy I. (2014). Quality of Life in Women With Breast Cancer and the Use of Complementary and Alternative Medicine. Holist Nurs Pract 28(4):258–264 32. Özdelikara A. (2013). Meme Kanserli Hastalarda Refleksolojinin Kemoterapiye Bağlı Bulantı, Kusma ve Yorgunluk Üzerine Etkisi. Atatürk Üniversitesi Sağlık Bilimleri Fakültesi. Erzurum. 33. Yeşil H, Kıran B, ALKAN H, ATEŞ B, KAYALI B, BÜYÜKÇAM S, GÜLER S, ÜNLÜ İ, SERT ZN, UYSAL M. (2018). Afyon Kocatepe Üniversitesi’nde Meme Kanseri Tanısı İle Takip Edilmekte Olan Hastalarda Tamamlayıcı Ve Alternatif Tedavi Kullanımı. Kocatepe Medical Journal 19:42-47.Nisan.
Year 2020,
Volume: 5 Issue: 1, 38 - 48, 30.04.2020
Abstract
References
- 1. https://www.uicc.org. new-global-cancer-data-globocan. 2018. 2. Cordosa F, Kyriakides S. (2019). Early Breast Cancer: ESMO Clinical Practice Guideline For Diagnosis, Treatment And Follow-Up. Annals Of Oncology 30: 1194–1220. 3. Breast Cancer Statistics 2019 in CA: A Cancer Journal for Clinicians. 4. Ozmen V. (2008). Breast Cancer in the world and Turkey. The Journal of Breast Health 4:1-4. 5. Aydıner A, Topuz E. (2006). Meme Kanseri Tanı , Tedavi ,Takip. İstanbul Konsensusu. Nobel Tıp Kitapevi. 6. Kurt S, Unsar S. (2011). Assessment of symptom control in patients with cancer in Northwestern Turkey. European Journal of Oncology Nursing 15 (2), 137-144. 7. Liao G, Apaya M, Shyur L. (2013). Herbal Medicine and Acupuncture for Breast Cancer Palliative Care and Adjuvant Therapy. Hindawi Publishing, 437, 17-23. 8. Algier LA, Hanoglu Z, Ozden G, Kara F. (2005). The use of complementary and alternative (non-conventional) medicine in cancer patients in Turkey. Eur J Oncol Nurs 9:138-46. 9. Ozlem ER, Mistik S, Ozkan M, Ozturk A, Altinbas M. (2008). Factors related to complementary/ alternative medicine use among cancer patients in central Anatolia. Tumori, 94, 833-7. 10. National Center for Complementary and Integrative Health [Internet]. Maryland: National Institutes of Health: 2017 [updated 2019 oct 14]. Available from: https://nccih.nih.gov/health/integrative-health 11. Yildirim YK, Fadiloğlu C, Uyar M. (2006). Complementary therapies in palliative cancer care. [Article in Turkish] Agri 18(1):26–32. 12. Libing Zhu, Lingru Li, Yingshuai Li, Ji Wang, Qi Wang. (2016). Chinese Herbal Medicine as an Adjunctive Therapy for Breast Cancer: A Systematic Review and Meta-Analysis. Evidence-based complementary and alternative medicine. 13. Tian H, Qin W Wenjing Wu, Pi Guo, Yong Lu,Pengxi Liu, Qiang Liu, Fengxi S. (2015). Effects of Traditional Chinese Medicine on Chemotherapy Induced Myelosuppression and Febrile Neutropenia in Breast Cancer Patients. Evidence-Based Complementary and Alternative Medicine. 14. Wu H‐J, Tai C‐J, Tai C‐J, Chien L‐Y. (2019). Symptom severity, symptom interference and use of complementary and alternative medicine among survivors of colorectal and breast cancer after curative treatment in Taiwan. European Journal of Cancer Care. 15. Kang E. Yang E.J. Kim SM, Chung IY, Han SA, Ku DH, Nam SJ, Yang JH, Kim SW. (2012). Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study. Support Care Cancer 20:461–473 16. Hwang HJ, Kim WY, Ahmed M, Choi S, Kim J, Han DW. (2015). The Use of Complementary and Alternative Medicine by Korean Breast Cancer Women: Is It Associated with Severity of Symptoms? Evidence-Based Complementary and Alternative Medicine. 17. Kang DH, McArdle T, Suh Y.(2014). Changes in Complementary and Alternative Medicine Use Across Cancer Treatment and Relationship to Stress, Mood, and Quality of Life. The Journal Of Alternatıve And Complementary Medıcıne. pp. 1–7 18. Jeong YJ, Kwak MA, Seo JC,Park SH, Bong JG, Shin IH , Park SH. (2018). Acupuncture for the Treatment of Taxane-Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot Trial. Evidence-Based Complementary and Alternative Medicine Volume 19. Saibul N, Shariff MZ, Rahmat A, Sulaiman S, Yaw YH. (2012). Use of Complementary and Alternative Medicine among Breast Cancer Survivors. Asian Pacific J Cancer Prev 13: 4081-4086 20. Chui PL, Abdullah KL, Wong LP, Taip NA. (2017). Complementary and Alternative Medicine Use and Symptom Burden in Women Undergoing Chemotherapy for Breast Cancer in Malaysia. Cancer Nursing. 21. McLay J.S. Stewart D, George J, Rore C, Heys SD. (2012). Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions? Eur J Clin Pharmacol 68:811–819 22. Alsharif FH, Mazanec SR. (2019). The use of complementary and alternative medicine among women with breast cancer in Saudi Arabia. Applied Nursing Research 48:75–80 23. Bright-Gbebry M, Makambi H, Rohan JP, Llanos AA, Rosenberg L, Palmer JR, Adams-Campbell LL. (2011). Use of multivitamins, folic acid and herbal supplements among breast cancer survivors: the black women’s health study. BMC Complementary and Alternative Medicine, 11:30 24. Rush CL, Lobo T, Serrano A, Blasini M, Campos C, Graves K.D. (2016). Complementary and Alternative Medicine Use and Latina Breast Cancer Survivors’ Symptoms and Functioning. Healthcare, 4, 80 25. Templeton AJ, Thürlimann B, Baumann M, Mark M, Stoll S, Schwizer M, Dietrich D, Ruhstaller T. (2013). Cross-sectional study of self-reported physical activity, eating habits and use of complementary medicine in breast cancer survivors. BMC Cancer, 13:153 26. Sarvarya A, Sarvarya A. (2019). Use of complementary and alternative medicine among breast cancer patients in Hungary: A descriptive study. Complementary Therapies in Clinical Practice 35:195–200 27. Yavuz M, Özcan İlçe A, Kaymakçı Ş, Bildik G, Dıramalı A. (2007). Meme Kanserli Hastaların Tamamlayıcı ve Alternatif Tedavi Yöntemlerini Kullanma Durumlarının İncelenmesi. Turkiye Klinikleri 680 J Med Sci, 27 28. Can G, Demir M, Aydıner A. (2012). Complementary and Alternative Therapies Used by Turkish Breast Cancer Patients Undergoing Chemotherapy. Breast Care. 7:471–475 29. Kurt H. Keşkek Ş, Çil T, Canataroğlu A. (2013). Meme kanserli hastalarda tamamlayıcı/ alternatif tedavi kullanımı. Türk Onkoloji Dergisi. 28(1):10-15 30. Aslan M. (2014). Meme Kanserli Kadın Hastalarda Kemoterapiye Bağlı Gelişen Bulantı, Kusma ve Öğürme Üzerine Zencefil Kullanımının Etkisi. Hacettepe Üniversitesi Sağlık Bilimleri Enstitüsü. Ankara. 31. Gül A, Üstündağ H, Andsoy I. (2014). Quality of Life in Women With Breast Cancer and the Use of Complementary and Alternative Medicine. Holist Nurs Pract 28(4):258–264 32. Özdelikara A. (2013). Meme Kanserli Hastalarda Refleksolojinin Kemoterapiye Bağlı Bulantı, Kusma ve Yorgunluk Üzerine Etkisi. Atatürk Üniversitesi Sağlık Bilimleri Fakültesi. Erzurum. 33. Yeşil H, Kıran B, ALKAN H, ATEŞ B, KAYALI B, BÜYÜKÇAM S, GÜLER S, ÜNLÜ İ, SERT ZN, UYSAL M. (2018). Afyon Kocatepe Üniversitesi’nde Meme Kanseri Tanısı İle Takip Edilmekte Olan Hastalarda Tamamlayıcı Ve Alternatif Tedavi Kullanımı. Kocatepe Medical Journal 19:42-47.Nisan.
There are 1 citations in total.
Details
| Primary Language | Turkish |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | Review |
| Authors | |
| Publication Date | April 30, 2020 |
| Published in Issue | Year 2020Volume: 5 Issue: 1 |
